Page last updated: 2024-11-07

metaraminol and Cerebrovascular Disorders

metaraminol has been researched along with Cerebrovascular Disorders in 8 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research Excerpts

ExcerptRelevanceReference
"Clomipramine which has a stimulating effect on oxygen metabolism should be kept in reserve for the chronic phase of prolonged coma."1.26[Prolonged traumatic and vascular coma: prognostic and therapeutic indications based on hemodynamic and metabolic studies]. ( Baldy-Moulinier, M; Escuret, E; Frèrebeau, P; Passouant, P; Roquefeuil, B, 1976)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19908 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FREMONT, RE1
JAGENDORF, B1
NYE, ER1
MACLEAN, LD1
DUFF, JH1
Farhat, SM1
Schneider, RC1
Baldy-Moulinier, M1
Roquefeuil, B1
Escuret, E1
Frèrebeau, P1
Passouant, P1
Harrison, MJ1
Sedal, L1
Arnold, J1
Russell, RW1
Bennett, HD1
Hoedt-Rasmussen, K1

Other Studies

8 other studies available for metaraminol and Cerebrovascular Disorders

ArticleYear
CLINICAL OBSERVATIONS ON THE EFFICACY OF METARAMINOL IN THE TREATMENT OF SHOCK.
    Current therapeutic research, clinical and experimental, 1964, Volume: 6

    Topics: Cerebrovascular Disorders; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Hypertension; Hypertensi

1964
THE EFFECT OF BLOOD PRESSURE ALTERATION ON THE PULSE WAVE VELOCITY.
    British heart journal, 1964, Volume: 26

    Topics: Aorta; Blood Pressure; Bromides; Cerebrovascular Disorders; Electrocardiography; Femoral Artery; Hea

1964
THE USE OF CENTRAL VENOUS PRESSURE AS A GUIDE TO VOLUME REPLACEMENT IN SHOCK.
    Diseases of the chest, 1965, Volume: 48

    Topics: Blood Pressure; Blood Transfusion; Blood Volume; Cardiac Output; Central Venous Pressure; Cerebrovas

1965
Observations on the effect of systemic blood pressure on intracranial circulation in patients with cerebrovascular insufficiency.
    Journal of neurosurgery, 1967, Volume: 27, Issue:5

    Topics: Acute Disease; Adult; Blood Pressure; Carotid Artery Diseases; Cerebrovascular Circulation; Cerebrov

1967
[Prolonged traumatic and vascular coma: prognostic and therapeutic indications based on hemodynamic and metabolic studies].
    Revue neurologique, 1976, Volume: 132, Issue:11

    Topics: Blood Gas Analysis; Brain; Carbon Dioxide; Cerebrovascular Circulation; Cerebrovascular Disorders; C

1976
No-reflow phenomenon in the cerebral circulation of the gerbil.
    Journal of neurology, neurosurgery, and psychiatry, 1975, Volume: 38, Issue:12

    Topics: Animals; Cerebrovascular Circulation; Cerebrovascular Disorders; Disease Models, Animal; Hypotension

1975
The management of massive gastrointestinal bleeding in the aged patient.
    Geriatrics, 1967, Volume: 22, Issue:3

    Topics: Aged; Blood Volume Determination; Cardiovascular Diseases; Cerebrovascular Disorders; Chromium Isoto

1967
Regional changes in cerebrovascular resistance during CO2 inhalation and the administration of Aramine in acute cerebrovascular disease.
    Acta neurologica Scandinavica, 1967, Volume: 43, Issue:S31

    Topics: Cerebrovascular Circulation; Cerebrovascular Disorders; Humans; Hyperemia; Metaraminol; Vasomotor Sy

1967